Pharma stock rally: Shares of IOL Chemicals and Pharmaceuticals Limited rallied nearly 14% during Monday’s intraday trading session after a surge in trading volume. The sharp spike in the pharmaceutical stock has come days after a 117% rally over the last six months.
While the stock has delivered strong returns over the past few months, its recently-announced quarterly results have sparked fresh interest among investors. IOL Chemicals and Pharmaceuticals’ net profit more than doubled during the second quarter of financial year 2026-27.
IOL Chemicals and Pharmaceuticals share price witnessed a sharp surge in trading volume by more than 8.81 times during Monday’s trading session. At 9:51 am, over 96,059 shares had changed hands during the trading session.
The company’s net profit surged to ₹65.03 crore in Q2FY27 against ₹30 crore reported in the year ago period. Its net revenue surged to ₹795.03 crore during the quarter under review against ₹567.53 crore reported in Q2FY27. Its net revenue from operations stood at ₹756.26 crore in Q1FY27.
“Our diversified business model has enabled us to sustain growth momentum amid continued geopolitical uncertainties and evolving global market conditions. Better product mix and operating efficiencies also contributed to a 321-basis-point year-on-year expansion in EBITDA margin,” stated Vikas Gupta, Joint Managing Director.